Goldman Sachs’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-101,423
| Closed | -$1.16M | – | 6577 |
|
|
2020
Q4 | $1.16M | Buy |
101,423
+75,243
| +287% | +$857K | ﹤0.01% | 4102 |
|
|
2020
Q3 | $181K | Buy |
26,180
+1,477
| +6% | +$9.7K | ﹤0.01% | 4953 |
|
|
2020
Q2 | $161K | Sell |
24,703
-14,230
| -37% | -$91.9K | ﹤0.01% | 4871 |
|
|
2020
Q1 | $257K | Sell |
38,933
-5,641
| -13% | -$49.2K | ﹤0.01% | 4594 |
|
|
2019
Q4 | $462K | Sell |
44,574
-3,010
| -6% | -$25.7K | ﹤0.01% | 4550 |
|
|
2019
Q3 | $301K | Sell |
47,584
-24,911
| -34% | -$186K | ﹤0.01% | 4684 |
|
|
2019
Q2 | $539K | Buy |
72,495
+57,517
| +384% | +$379K | ﹤0.01% | 4369 |
|
|
2019
Q1 | $92K | Sell |
14,978
-12,233
| -45% | -$142K | ﹤0.01% | 4939 |
|
|
2018
Q4 | $313K | Sell |
27,211
-3,514
| -11% | -$60K | ﹤0.01% | 4610 |
|
|
2018
Q3 | $665K | Buy |
30,725
+3,670
| +14% | +$69.4K | ﹤0.01% | 4264 |
|
|
2018
Q2 | $427K | Buy |
27,055
+12,085
| +81% | +$190K | ﹤0.01% | 4611 |
|
|
2018
Q1 | $282K | Buy |
14,970
+1,288
| +9% | +$25.4K | ﹤0.01% | 4815 |
|
|
2017
Q4 | $238K | Sell |
13,682
-659,832
| -98% | -$9.11M | ﹤0.01% | 5324 |
|
|
2017
Q3 | $10.1M | Sell |
673,514
-27,630
| -4% | -$434K | ﹤0.01% | 2546 |
|
|
2017
Q2 | $13M | Sell |
701,144
-8,063
| -1% | -$140K | ﹤0.01% | 2303 |
|
|
2017
Q1 | $12M | Sell |
709,207
-3,201
| -0.4% | -$63.9K | ﹤0.01% | 2268 |
|
|
2016
Q4 | $15.2M | Sell |
712,408
-30,756
| -4% | -$631K | ﹤0.01% | 2157 |
|
|
2016
Q3 | $13.6M | Buy |
743,164
+235,608
| +46% | +$5.31M | ﹤0.01% | 2205 |
|
|
2016
Q2 | $14.7M | Buy |
+507,556
| New | +$14.1M | ﹤0.01% | 2024 |
|
Goldman Sachs's ARA Position: Q1 2021 in Review
Goldman Sachs sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 101,423 shares — an estimated $1.16M sold.
Goldman Sachs first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $15.2M in Q4 2016. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Goldman Sachs reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Goldman Sachs sold 101,423 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $1.16M.
- Goldman Sachs first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- Goldman Sachs's American Renal Associates Holdings, Inc position peaked at $15.2M in Q4 2016.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Goldman Sachs's 13F filing for Q1 2021, filed 17 May 2021.